Macrophage Migration Inhibitory Factor-An Innovative Indicator for Free Flap Ischemia after Microsurgical Reconstruction
- PMID: 34063809
- PMCID: PMC8223971
- DOI: 10.3390/healthcare9060616
Macrophage Migration Inhibitory Factor-An Innovative Indicator for Free Flap Ischemia after Microsurgical Reconstruction
Abstract
(1) Background: Nowadays, the use of microsurgical free flaps is a standard operative procedure in reconstructive surgery. Still, thrombosis of the microanastomosis is one of the most fatal postoperative complications. Clinical evaluation, different technical devices and laboratory markers are used to monitor critical flap perfusion. Macrophage migration inhibitory factor (MIF), a structurally unique cytokine with chemokine-like characteristics, could play a role in predicting vascular problems and the failure of flap perfusion. (2) Methods: In this prospective observational study, 26 subjects that underwent microsurgical reconstruction were observed. Besides clinical data, the number of blood leukocytes, CRP and MIF were monitored. (3) Results: Blood levels of MIF, C-reactive protein (CRP) and leukocytes increased directly after surgery. Subjects that needed surgical revision due to thrombosis of the microanastomosis showed significantly higher blood levels of MIF than subjects without revision. (4) Conclusion: We conclude that MIF is a potential and innovative indicator for thrombosis of the microanastomosis after free flap surgery. Since it is easy to obtain diagnostically, MIF could be an additional tool to monitor flap perfusion besides clinical and technical assessments.
Keywords: free flap surgery; innovative surgical methods; ischemia; macrophage migration inhibitory factor (MIF); microanastomosis.
Conflict of interest statement
Jürgen Bernhagen was supported by Deutsche Forschungsgemeinschaft (DFG) grant BE 1977/11-1 to J.B., by DFG under Germany’s Excellence Strategy within the framework of the Munich Cluster for Systems Neurology (EXC 2145 SyNergy–ID 390857198). Ioannis-Fivos Megas, David Simons, Bong-Sung Kim, Christian Stoppe, Andrzej Piatkowski, Panagiotis Fikatas, Paul Christian Fuchs, Jacqueline Bastiaanse, Norbert Pallua, Jürgen Bernhagen and Gerrit Grieb report no proprietary or commercial interest in any product mentioned or concept discussed in this article.
Figures






Similar articles
-
Macrophage migration inhibitory factor is a potential inducer of endothelial progenitor cell mobilization after flap operation.Surgery. 2012 Feb;151(2):268-277.e1. doi: 10.1016/j.surg.2010.10.008. Epub 2010 Dec 30. Surgery. 2012. PMID: 21193209
-
The effect of the macrophage migration inhibitory factor (MIF) on excisional wound healing in vivo.J Plast Surg Hand Surg. 2020 Jun;54(3):137-144. doi: 10.1080/2000656X.2019.1710710. Epub 2020 Apr 11. J Plast Surg Hand Surg. 2020. PMID: 32281469
-
Pilot study: elevated circulating levels of the proinflammatory cytokine macrophage migration inhibitory factor in patients with chronic spinal cord injury.Arch Phys Med Rehabil. 2013 Aug;94(8):1498-507. doi: 10.1016/j.apmr.2013.04.004. Epub 2013 Apr 22. Arch Phys Med Rehabil. 2013. PMID: 23618747
-
Macrophage Migration Inhibitory Factor in Clinical Kidney Disease.Front Immunol. 2016 Jan 26;7:8. doi: 10.3389/fimmu.2016.00008. eCollection 2016. Front Immunol. 2016. PMID: 26858715 Free PMC article. Review.
-
The vascular biology of macrophage migration inhibitory factor (MIF). Expression and effects in inflammation, atherogenesis and angiogenesis.Thromb Haemost. 2013 Mar;109(3):391-8. doi: 10.1160/TH12-11-0831. Epub 2013 Jan 17. Thromb Haemost. 2013. PMID: 23329140 Review.
Cited by
-
Free flaps monitoring by Laser-Doppler Flowmetry in head and neck surgery.Acta Otorhinolaryngol Ital. 2022 Oct;42(5):427-433. doi: 10.14639/0392-100X-N1956. Acta Otorhinolaryngol Ital. 2022. PMID: 36541380 Free PMC article.
-
The Role of Macrophage Migration Inhibitory Factor (MIF) and D-Dopachrome Tautomerase (D-DT/MIF-2) in Infections: A Clinical Perspective.Biomedicines. 2023 Dec 19;12(1):2. doi: 10.3390/biomedicines12010002. Biomedicines. 2023. PMID: 38275363 Free PMC article. Review.
-
Apoptotic Bodies Derived from Fibroblast-Like Cells in Subcutaneous Connective Tissue Inhibit Ferroptosis in Ischaemic Flaps via the miR-339-5p/KEAP1/Nrf2 Axis.Adv Sci (Weinh). 2024 Jun;11(24):e2307238. doi: 10.1002/advs.202307238. Epub 2024 Apr 19. Adv Sci (Weinh). 2024. PMID: 38639443 Free PMC article.
References
-
- Whitaker I.S., Rozen W.M., Chubb D., Acosta R., Kiil B.J., Birke-Sorensen H., Grinsell D., Ashton M.W. Postoperative moni-toring of free flaps in autologous breast reconstruction: A multicenter comparison of 398 flaps using clinical monitoring, mi-crodialysis, and the implantable Doppler probe. J. Reconstr. Microsurg. 2010;26:409–416. doi: 10.1055/s-0030-1249607. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous